The FLCCC Alliance is proud to announce it has partnered with renowned breast cancer physician and researcher Kathleen Ruddy, MD, to conduct an observational study in collaboration with five U.S. clinics to track patient responses to various adjunct cancer therapies using repurposed drugs.
Dr. Ruddy and Dr. Marik will act as lead investigators with Dr. Pierre Kory acting as contributing author. Five clinics will participate in the study:
Health and Healing, led by Kathleen Ruddy, MD
Leading Edge Clinic, led by Pierre Kory, MD, MPA and Scott Marsland, FNP-C
Brio Medical, a holistic, integrative cancer healing center, led by Nathan Goodyear, MD, MD(H), ABAARM, FMNM
James Clinic, led by Mollie James, DO, MPH, FACOS FACS, IFMCP
Meakin Metabolic Care, led by Charles Meakin, MD
Learn more:
The post FLCCC Launches Observational Cancer Study Focused on Repurposed Drugs appeared first on FLCCC Alliance.
0 comments on “FLCCC Launches Observational Cancer Study Focused on Repurposed Drugs” Add yours →